Genmab A/S

CSE:GMAB

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is GMAB's stock price target?

Price Target

2 770.13 DKK

According to Wall Street analysts, the average 1-year price target for GMAB is 2 770.13 DKK with a low forecast of 1 878.6 DKK and a high forecast of 5 145 DKK.

What is Genmab A/S's Revenue forecast?

Projected CAGR

19%

For the last 8 years the compound annual growth rate for Genmab A/S's revenue is 40%. The projected CAGR for the next 3 years is 19%.

What is Genmab A/S's Operating Income forecast?

Projected CAGR

25%

For the last 8 years the compound annual growth rate for Genmab A/S's operating income is 28%. The projected CAGR for the next 3 years is 25%.

What is Genmab A/S's Net Income forecast?

Projected CAGR

27%

For the last 8 years the compound annual growth rate for Genmab A/S's net income is 24%. The projected CAGR for the next 3 years is 27%.